Effects of Intracerebroventricularly (ICV) Injected Ghrelin on Cardiac Inducible Nitric Oxide Synthase Activity/Expression in Obese Rats

 

 Buy Article Permissions and Reprints

Abstract

The aim of this study was to examine the effects of ghrelin on regulation of cardiac inducible nitric oxide synthase (iNOS) activity/expression in high fat (HF), obese rats.

For this study, male Wistar rats fed with HF diet (30% fat) for 4 weeks were injected every 24 h for 5 days intracerebroventriculary (ICV) with ghrelin (0.3 nmol/5 µl) or with an equal volume of phosphate buffered saline (PBS). Control rats were ICV injected with an equal volume of PBS. Glucose, insulin and nitric oxide (NO) concentrations were measured in serum, while arginase activity and citrulline concentrations were measured in heart lysate. Protein iNOS and regulatory subunit of nuclear factor-κB (NFκB-p65), phosphorylation of enzymes protein kinase B (Akt) at Ser⁴⁷³, and extracellular signal-regulated kinases 1/2 (ERK1/2) at Tyr²⁰²/Tyr²⁰⁴ were determined in heart lysate by Western blot. For gene expression of iNOS qRT-PCR was used.

Results show significantly (p<0.01) higher serum NO production in ghrelin treated HF rats compared with HF rats. Ghrelin significantly reduced citrulline concentration (p<0.05) and arginase activity (p<0.01) in HF rats. In ghrelin treated HF rats, gene and protein expression of iNOS and NFκB-p65 levels were significantly (p<0.05) increased compared with HF rats. Increased phosphorylation of Akt (p<0.01) and decreased (p<0.05) ERK1/2 phosphorylation were detected in HF ghrelin treated rats compared with HF rats hearts.

Results from this study indicate that exogenous ghrelin induces expression and activity of cardiac iNOS via Akt phosphorylation followed by NFκB activation in HF rats.

• References

• 1 Kojima M, Kangawa K. Ghrelin: structure and function. Physiol Rev 2005; 85: 495-522
  CrossrefPubMedGoogle Scholar
• 2 Korbonits M, Goldstone AP, Gueorguiev M et al. Ghrelin – a hormone with multiple functions. Front Neuroendocrinol 2004; 25: 27-68
  CrossrefPubMedGoogle Scholar
• 3 Pulkkinen L, Ukkola O, Kolehmainen M et al. Ghrelin in diabetes and metabolic syndrome. Int J Pept 2010; 2010
  PubMedGoogle Scholar
• 4 Sudar E, Dobutovic B, Soskic S et al. Regulation of inducible nitric oxide synthase activity/expression in rat hearts from ghrelin-treated rats. J Physiol Biochem 2011; 67: 195-204
  CrossrefPubMedGoogle Scholar
• 5 Zhang G, Yin X, Qi Y et al. Ghrelin and cardiovascular diseases. Curr Cardiol Rev 2010; 6: 62-70
  CrossrefPubMedGoogle Scholar
• 6 Tesauro M, Schinzari F, Iantorno M et al. Ghrelin improves endothelial function in patients with metabolic syndrome. Circulation 2005; 112: 2986-2992
  PubMedGoogle Scholar
• 7 Wang Y, Narsinh K, Zhao L et al. Effects and mechanisms of ghrelin on cardiac microvascular endothelial cells in rats. Cell Biol Int 2011; 35: 135-140
  CrossrefPubMedGoogle Scholar
• 8 Matsumura K, Tsuchihashi T, Fujii K et al. Central ghrelin modulates sympathetic activity in conscious rabbits. Hypertension 2002; 40: 694-699
  CrossrefPubMedGoogle Scholar
• 9 Okumura H, Nagaya N, Enomoto M et al. Vasodilatory effect of ghrelin, an endogenous peptide from the stomach. J Cardiovasc Pharmacol 2002; 39: 779-783
  CrossrefPubMedGoogle Scholar
• 10 Xie Q, Nathan C. The high-output nitric oxide pathway: role and regulation. J Leukoc Biol 1994; 56: 576-582
  PubMedGoogle Scholar
• 11 Balligand JL, Cannon PJ. Nitric oxide synthases and cardiac muscle. Autocrine and paracrine influences. Arterioscler Thromb Vasc Biol 1997; 17: 1846-1858
  CrossrefPubMedGoogle Scholar
• 12 Iantorno M, Chen H, Kim JA et al. Ghrelin has novel vascular actions that mimic PI 3-kinase-dependent actions of insulin to stimulate production of NO from endothelial cells. Am J Physiol Endocrinol Metab 2007; 292: E756-E764
  PubMedGoogle Scholar
• 13 Isenovic E, LaPointe MC. Role of Ca(2+)-independent phospholipase A(2) in the regulation of inducible nitric oxide synthase in cardiac myocytes. Hypertension 2000; 35: 249-254
  CrossrefPubMedGoogle Scholar
• 14 Isenovic E, Walsh MF, Muniyappa R et al. Phosphatidylinositol 3-kinase may mediate isoproterenol-induced vascular relaxation in part through nitric oxide production. Metabolism 2002; 51: 380-386
  CrossrefPubMedGoogle Scholar
• 15 Kim JA, Montagnani M, Koh KK et al. Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Circulation 2006; 113: 1888-1904
  CrossrefPubMedGoogle Scholar
• 16 Strijdom H, Friedrich SO, Hattingh S et al. Hypoxia-induced regulation of nitric oxide synthase in cardiac endothelial cells and myocytes and the role of the PI3-K/PKB pathway. Mol Cell Biochem 2009; 321: 23-35
  CrossrefPubMedGoogle Scholar
• 17 Rao KM. Molecular mechanisms regulating iNOS expression in various cell types. J Toxicol Environ Health B. Crit Rev 2000; 3: 27-58
  PubMedGoogle Scholar
• 18 Dimmeler S, Fleming I, Fisslthaler B et al. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 1999; 399: 601-605
  CrossrefPubMedGoogle Scholar
• 19 Buettner R, Scholmerich J, Bollheimer LC. High-fat diets: modeling the metabolic disorders of human obesity in rodents. Obesity (Silver Spring) 2007; 15: 798-808
  CrossrefPubMedGoogle Scholar
• 20 Starcevic VP, Morrow BA, Farner LA et al. Long-term recording of cerebrospinal fluid pressure in freely behaving rats. Brain Res 1988; 462: 112-117
  CrossrefPubMedGoogle Scholar
• 21 Stevanovic D, Nesic D, Milosevic V et al. Consummatory behavior and metabolic indicators after central ghrelin injections in rats. Regul Pept 2008; 147: 52-59
  CrossrefPubMedGoogle Scholar
• 22 Stevanovic D, Starcevic V, Vilimanovich U et al. Immunomodulatory actions of central ghrelin in diet-induced energy imbalance. Brain Behav Immun 2012; 26: 150-158
  CrossrefPubMedGoogle Scholar
• 23 Shimizu Y, Nagaya N, Teranishi Y et al. Ghrelin improves endothelial dysfunction through growth hormone-independent mechanisms in rats. Biochem Biophys Res Commun 2003; 310: 830-835
  CrossrefPubMedGoogle Scholar
• 24 Matthews DR, Hosker JP, Rudenski AS et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419
  Google Scholar
• 25 Hevel JM, Marletta MA. Nitric-oxide synthase assays. Methods Enzymol 1994; 233: 250-258
  PubMedGoogle Scholar
• 26 Corraliza IM, Campo ML, Soler G et al. Determination of arginase activity in macrophages: a micromethod. J Immunol Methods 1994; 174: 231-235
  CrossrefPubMedGoogle Scholar
• 27 Boyde TR, Rahmatullah M. Optimization of conditions for the colorimetric determination of citrulline, using diacetyl monoxime. Anal Biochem 1980; 107: 424-431
  CrossrefPubMedGoogle Scholar
• 28 Fearon WR. The carbamido diacetyl reaction: a test for citrulline. Biochem J 1939; 33: 902-907
  CrossrefPubMedGoogle Scholar
• 29 Sudar E, Dobutovic B, Milosavljevic T et al. Interactive effects of insulin and β-estradiol on protein kinase b phosphorylation in adult rat cardiomyocytes. Acta Chimica Slovenica 2009; 56: 723-728
  PubMedGoogle Scholar
• 30 Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25: 402-408
  CrossrefPubMedGoogle Scholar
• 31 Hou CH, Lin J, Huang SC et al. Ultrasound stimulates NF-kappaB activation and iNOS expression via the Ras/Raf/MEK/ERK signaling pathway in cultured preosteoblasts. J Cell Physiol 2009; 220: 196-203
  CrossrefPubMedGoogle Scholar
• 32 Nathan C, Xie QW. Regulation of biosynthesis of nitric oxide. J Biol Chem 1994; 269: 13725-1378
  PubMedGoogle Scholar
• 33 Dobutovic B, Sudar E, Tepavcevic S et al. Effects of ghrelin on protein expression of antioxidative enzymes and iNOS in the rat liver. Arch Med Sci 2014; 10: 806-816
  PubMedGoogle Scholar
• 34 Barnard RJ, Roberts CK, Varon SM et al. Diet-induced insulin resistance precedes other aspects of the metabolic syndrome. J Appl Physiol (1985) 1998; 84: 1311-1315
  PubMedGoogle Scholar
• 35 Reil TD, Barnard RJ, Kashyap VS et al. Diet-induced changes in endothelial-dependent relaxation of the rat aorta. J Surg Res 1999; 85: 96-100
  CrossrefPubMedGoogle Scholar
• 36 Obradovic M, Sudar E, Zafirovic S et al. Estradiol In Vivo Induces Changes in Cardiomyocytes Size in Obese Rats. Angiology 2015; 66: 25-35
  CrossrefPubMedGoogle Scholar
• 37 Nakazato M, Murakami N, Date Y et al. A role for ghrelin in the central regulation of feeding. Nature 2001; 409: 194-198
  CrossrefPubMedGoogle Scholar
• 38 Tschop M, Smiley DL, Heiman ML. Ghrelin induces adiposity in rodents. Nature 2000; 407: 908-913
  CrossrefPubMedGoogle Scholar
• 39 Wan G, Ohnomi S, Kato N. Increased hepatic activity of inducible nitric oxide synthase in rats fed on a high-fat diet. Biosci Biotechnol Biochem 2000; 64: 555-561
  CrossrefPubMedGoogle Scholar
• 40 Jia YX, Pan CS, Yang JH et al. Altered L-arginine/nitric oxide synthase/nitric oxide pathway in the vascular adventitia of rats with sepsis. Clin Exp Pharmacol Physiol 2006; 33: 1202-1208
  CrossrefPubMedGoogle Scholar
• 41 Morris Jr SM. Arginine metabolism in vascular biology and disease. Vasc Med 2005; 10 (Suppl. 01) S83-S87
  CrossrefPubMedGoogle Scholar
• 42 Wu G, Morris Jr SM. Arginine metabolism: nitric oxide and beyond. Biochem J 1998; 336: 1-17
  CrossrefPubMedGoogle Scholar
• 43 Zhao D, Zhan Y, Zeng H et al. Ghrelin stimulates interleukin-8 gene expression through protein kinase C-mediated NF-kappaB pathway in human colonic epithelial cells. J Cell Biochem 2006; 97: 1317-1327
  CrossrefPubMedGoogle Scholar
• 44 Lowenstein CJ. NO news is good news. Proc Natl Acad Sci USA 1999; 96: 10953-10954
  CrossrefPubMedGoogle Scholar
• 45 Maulik N, Sato M, Price BD et al. An essential role of NFkappaB in tyrosine kinase signaling of p38 MAP kinase regulation of myocardial adaptation to ischemia. FEBS Lett 1998; 429: 365-369
  CrossrefPubMedGoogle Scholar
• 46 Baldanzi G, Filigheddu N, Cutrupi S et al. Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT. J Cell Biol 2002; 159: 1029-1037
  CrossrefPubMedGoogle Scholar
• 47 Chung H, Seo S, Moon M et al. Phosphatidylinositol-3-kinase/Akt/glycogen synthase kinase-3 beta and ERK1/2 pathways mediate protective effects of acylated and unacylated ghrelin against oxygen-glucose deprivation-induced apoptosis in primary rat cortical neuronal cells. J Endocrinol 2008; 198: 511-521
  CrossrefPubMedGoogle Scholar
• 48 Granata R, Settanni F, Biancone L et al. Acylated and unacylated ghrelin promote proliferation and inhibit apoptosis of pancreatic beta-cells and human islets: involvement of 3′,5′-cyclic adenosine monophosphate/protein kinase A, extracellular signal-regulated kinase 1/2, and phosphatidyl inositol 3-Kinase/Akt signaling. Endocrinology 2007; 148: 512-529
  CrossrefPubMedGoogle Scholar
• 49 Kim JW, Kim C. Inhibition of LPS-induced NO production by taurine chloramine in macrophages is mediated though Ras-ERK-NF-kappaB. Biochem Pharmacol 2005; 70: 1352-1360
  CrossrefPubMedGoogle Scholar
• 50 Ellerhorst JA, Ekmekcioglu S, Johnson MK et al. Regulation of iNOS by the p44/42 mitogen-activated protein kinase pathway in human melanoma. Oncogene 2006; 25: 3956-3962
  CrossrefPubMedGoogle Scholar
• 51 Xiao Z, Wang T, Qin H et al. Endoplasmic reticulum Ca2+release modulates endothelial nitric-oxide synthase via extracellular signal-regulated kinase (ERK) 1/2-mediated serine 635 phosphorylation. J Biol Chem 2011; 286: 20100-20108
  CrossrefPubMedGoogle Scholar
• 52 Ahmed KM, Dong S, Fan M et al. Nuclear factor-kappaB p65 inhibits mitogen-activated protein kinase signaling pathway in radioresistant breast cancer cells. Mol Cancer Res 2006; 4: 945-955
  CrossrefPubMedGoogle Scholar
• 53 Nagaya N, Uematsu M, Kojima M et al. Chronic administration of ghrelin improves left ventricular dysfunction and attenuates development of cardiac cachexia in rats with heart failure. Circulation 2001; 104: 1430-1435
  CrossrefPubMedGoogle Scholar
• 54 Volterrani M, Manelli F, Cicoira M et al. Role of growth hormone in chronic heart failure. Therapeutic implications. Drugs 2000; 60: 711-719
  CrossrefPubMedGoogle Scholar
• 55 Hasdai D, Rizza RA, Holmes Jr. DR et al. Insulin and insulin-like growth factor-I cause coronary vasorelaxation in vitro. Hypertension 1998; 32: 228-234
  CrossrefPubMedGoogle Scholar
• 56 Walsh MF, Barazi M, Pete G et al. Insulin-like growth factor I diminishes in vivo and in vitro vascular contractility: role of vascular nitric oxide. Endocrinology 1996; 137: 1798-1803
  PubMedGoogle Scholar
• 57 Isenovic ER, Divald A, Milivojevic N et al. Interactive effects of insulin-like growth factor-1 and beta-estradiol on endothelial nitric oxide synthase activity in rat aortic endothelial cells. Metabolism 2003; 52: 482-487
  CrossrefPubMedGoogle Scholar
• 58 Boger RH, Bode-Boger SM, Frolich JC. The L-arginine-nitric oxide pathway: role in atherosclerosis and therapeutic implications. Atherosclerosis 1996; 127: 1-11
  CrossrefPubMedGoogle Scholar
• 59 Stevanovic D, Milosevic V, Nesic D et al. Central effects of ghrelin on serum growth hormone and morphology of pituitary somatotropes in rats. Exp Biol Med (Maywood) 2006; 231: 1610-1615
  PubMedGoogle Scholar
• 60 Dembinski A, Warzecha Z, Ceranowicz P et al. Variable effect of ghrelin administration on pancreatic development in young rats. Role of insulin-like growth factor-1. J Physiol Pharmacol 2005; 56: 555-570
  PubMedGoogle Scholar
• 61 Alvarez-Castro P, Isidro ML, Garcia-Buela J et al. Marked GH secretion after ghrelin alone or combined with GH-releasing hormone (GHRH) in obese patients. Clin Endocrinol (Oxf) 2004; 61: 250-255
  CrossrefPubMedGoogle Scholar
• 62 Hosoda H, Kangawa K. The autonomic nervous system regulates gastric ghrelin secretion in rats. Regul Pept 2008; 146: 12-18
  CrossrefPubMedGoogle Scholar
• 63 Iwakura H, Akamizu T, Ariyasu H et al. Effects of ghrelin administration on decreased growth hormone status in obese animals. Am J Physiol Endocrinol Metab 2007; 293: E819-E825
  CrossrefPubMedGoogle Scholar